Skip to content

Intensified multifactorial intervention on renal outcomes in DKD outpatients

Intensified multifactorial intervention on renal outcomes in DKD outpatients - Intensified multifactorial intervention on renal outcomes in DKD outpatients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000037889
Enrollment
240
Registered
2019-10-15
Start date
2019-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic kidney disease

Interventions

Outpatient-intensive treatment by using a management target sheet (+) Outpatient-intensive treatment by using a management target sheet (-)

Sponsors

Japan community healthcare organization
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients who have a new visit to the Department of Nephrology and are scheduled to go to the hospital for more than half a year 2) Diabetic patients in the course of diabetic kidney disease 3) Diabetic nephropathy stage 2 to 4 4) Patients who are 18 years old or older and younger than 90 years old at the time of registration 5) Gender: Any gender 6) General condition that allows medical care in an outpatient setting 7) Patients who have no complications of heart, brain or vascular disease or are in a stable condition 8) Patients whose written consent was obtained by the patient's own free will

Exclusion criteria

Exclusion criteria: 1) Patients who require hospitalization or new treatment at the time of registration 2) Patients suffering from serious malignant diseases, infections, heart, brain, blood vessels, liver diseases 3) Patients suffering from malignant diseases, infectious diseases, heart, brain, blood vessels, and liver diseases that are considered to have a limited life prognosis within half a year 4) Patients with eGFR of 15 ml / min or less and uremic symptoms 5) Female patients who are pregnant or may be pregnant 6) Patients with primary chronic glomerulonephritis (IgA nephropathy, membranous nephropathy, minimal change nephrosis) 7) Patients with purpura nephropathy, lupus nephritis, systemic vasculitis 8) Patients with acute renal failure at the time of registration 9) Patients who have prerenal failure and postrenal failure at the time of registration 10) When the research supervisor or research director determines that participation in this research is not appropriate

Design outcomes

Primary

MeasureTime frame
end stage kidney disease

Secondary

MeasureTime frame
anunual eGFR change rate,MACE,urinary protein change,achievement level of management targets sheet

Countries

Japan

Contacts

Public ContactHonami Mori

JCHO Saitama Northern Medical Center Department of Nephropathy

honamimori33@gmail.com0486631671

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026